pembrolizumab
merck
['melsm', 'melanoma', 'pembro']
adjuvant pembrolizumab results in significant dmfs improvement over placebo in stage ii melanoma #asco22 #melsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.